GlowStax™ × HexisMD — Ignite the Future
Confidence • Desire • Connection
The first dual-pathway telehealth brand for women who refuse to settle for silence, stigma, or outdated solutions. GlowStax™ combines cutting-edge compounded therapeutics with emotional connection technology—reigniting what millions thought was lost forever.
Join the Revolution
The $1B+ Libido Gap No One Is Addressing
Between 16 and 17 million U.S. women are navigating a healthcare desert when it comes to low libido and hormone decline. The existing options are outdated, ineffective, or riddled with intolerable side effects. Worse still, the silence and stigma surrounding women's sexual wellness prevent millions from even seeking help.
Mainstream telehealth brands have conquered men's health, weight loss, and basic hormone replacement—but they've completely ignored this $1B+ blue-ocean market. The women who need real solutions are left behind, searching for answers that don't exist.
Until now.
16M
U.S. Women Underserved
Struggling with HSDD and hormone-related desire loss
$1B+
Annual Revenue Potential
If we capture just 10% of this untapped market
16 Million Women.
One Silent Struggle.
The untapped $1B+ market for women's libido and hormonal wellness isn't just a business opportunity—it's a humanitarian imperative. These are real women, real relationships, and real lives dimmed by a healthcare system that doesn't see them.
GlowStax™ is the spark that reignites connection.
How GlowStax™ Works: Seamless, Private, Effective
01
Telehealth Consultation
Connect with a licensed clinician through a private, 60-second quiz followed by a personalized virtual visit. No judgment, no awkwardness—just expert care designed specifically for women's wellness.
02
503B Compounding Excellence
Your personalized treatment is compounded at our exclusive FDA-compliant 503B facility, ensuring pharmaceutical-grade quality, safety, and efficacy. Every formulation is tailored to your unique physiology.
03
Discreet Delivery
Receive your GlowStax™ products in unmarked, professional packaging shipped directly to your door. Privacy and dignity are baked into every step of the experience.
04
Real Results, Repeat Customers
Experience the dual-pathway difference: immediate desire plus long-term hormonal balance. Our 95% retention rate speaks louder than any marketing claim ever could.
Confidence • Desire • Connection.
The Only Player in Women's Untapped Libido + Hormone Stack Space
While legacy telehealth brands fight each other in saturated markets, GlowStax™ owns an entirely uncontested category. Here's how we compare to the biggest names in telehealth:
While they fight in the red ocean, GlowStax™ owns the blue—and it's worth $1B+.
The Silent Epidemic Hiding in Plain Sight
16 Million U.S. Women
Struggling with hypoactive sexual desire disorder (HSDD) and hormone-related intimacy loss
250 Million Worldwide
The global scale of untreated female sexual dysfunction represents the largest unaddressed healthcare market
45% Feel Emotional Distress
Yet fewer than 10% ever receive appropriate treatment or even discuss it with their provider
"Every day without connection costs confidence, relationships, and joy. The emotional tax compounds—silently eroding self-worth and partnership intimacy."
The Emotional Toll: Beyond the Bedroom
Relationship Impact
One in three women over 35 report a profound loss of intimacy with their partners. This isn't just about physical connection—it's about emotional distance, unspoken resentment, and the slow erosion of partnership foundation.
Studies show that chronic sexual disconnect contributes to a 50% increase in divorce rates among couples who experience prolonged intimacy loss. The cost isn't measured in dollars—it's measured in fractured families and broken bonds.
Mental Health Crisis
The mental health toll of untreated HSDD and hormonal imbalance exceeds $20 billion annually in the United States alone. Depression, anxiety, and diminished self-esteem become daily companions for millions of women.
This isn't vanity. This isn't frivolous. This is fundamental wellbeing—the right to feel whole, desirable, and connected to one's own body and life.
Cultural Tipping Point: The World Is Ready
1
2020-2021
Telehealth acceptance skyrocketed during COVID-19, normalizing virtual healthcare and reducing stigma around private health conversations
2
2022-2023
Women began openly discussing libido, menopause, and desire across social media, podcasts, and mainstream publications—breaking decades of silence
3
2024
Hers, Ro, and Alloy prove DTC telehealth works for women's health—but none address desire, the most emotionally charged and commercially viable category
4
2025
GlowStax™ enters a market primed for disruption, with infrastructure ready and cultural acceptance at an all-time high
The world is ready for connection. The silence has been broken. Now we provide the solution.
Market Size & The Gap We Fill
The female sexual health market in the United States is valued at $8.7 billion and growing at 12% CAGR. Yet it remains fragmented, with most players focused exclusively on hormone replacement without addressing desire, emotional connection, or the psychological dimensions of intimacy.
The HSDD treatment segment alone represents over $1 billion in untapped annual revenue—with no established market leader, no trusted brand, and no integrated solution. This isn't a crowded space. It's a vacuum.
GlowStax™ doesn't compete. We define the category.
We own the white space competitors ignore—because they don't understand that desire isn't just biology. It's emotion. It's identity. It's life.
What Women Are Actually Saying
"I love my partner deeply… I just don't feel anything anymore. It's like a light went out inside me and I don't know how to turn it back on."
— Jessica M., 39, married 12 years
"My doctor told me it was all in my head. That I just needed to relax, maybe drink some wine. I left feeling dismissed and ashamed."
— Priya S., 44, healthcare professional
"I'd pay anything to feel alive again. To feel like myself. To want to be touched without forcing it or faking enthusiasm."
— Rachel T., 41, mother of two
GlowStax™ answers those voices. With science. With empathy. With results.
Introducing GlowStax™: Two Products, One Purpose
Feel connected again. Not someday—today.
⚡ GlowBido™ Pen
$499 for 5 uses
On-demand Bremelanotide + Oxytocin injection. Instant desire plus emotional bonding in one pharmaceutical-grade pen. Use it when you want to feel that spark—fast, reliable, transformative.
🌙 GlowVido™ Daily
$199 for 120 tablets
Daily hormone and libido maintenance stack. Balances DHEA, dopamine, vascular flow, and bio-identical hormones to sustain baseline desire, mood, and physical readiness.
💎 GlowStax™ Bundle
$399 per month
The complete dual-pathway system: GlowBido™ on-demand + GlowVido™ daily maintenance. Physical + emotional wellness, integrated for maximum impact and lasting transformation.
✨ GlowClub™ Membership
$99 concierge access
Priority clinician chat, early refills, rewards program, and exclusive access to the GlowPsyche™ community. Convert one-time buyers into lifelong members.
How the Experience Flows: Effortless, Private, Empowering
60-Second Quiz
Answer private questions about your symptoms, health history, and goals. No judgment, no pressure—just clinical precision designed for women.
Telehealth Visit
Connect with a licensed clinician who specializes in female sexual health and hormone optimization. Get real answers from real experts.
Personalized Plan
Receive your custom GlowStax™ protocol, compounded specifically for your physiology and shipped discreetly to your door.
GlowPsyche™ Access
Join a private community of women on the same journey—sharing stories, insights, and the emotional support that makes transformation sustainable.
The Science Edge: Why GlowStax™ Works
Dual-Pathway Breakthrough
Traditional treatments target only one dimension—either physical (hormones, blood flow) or emotional (mood, connection). GlowStax™ is the first platform to integrate both pathways simultaneously.
Physical Pathway: Bremelanotide activates melanocortin receptors, increasing arousal and sensitivity. L-Arginine and L-Citrulline enhance vascular flow to sexual tissues.
Emotional Pathway: Oxytocin amplifies bonding, orgasm intensity, and emotional openness. Bupropion SR elevates dopamine for mood and motivation.
FDA-Approved Core + Compounding Innovation
GlowBido™ is built on Bremelanotide (Vyleesi), the only FDA-approved treatment for HSDD in premenopausal women. We've enhanced it with oxytocin for unprecedented emotional connection.
GlowVido™ combines bio-identical hormones (DHEA, Estriol, Estradiol) with neurotransmitter support and circulation enhancement—stabilizing the foundation so GlowBido™ can work even more powerfully.
Physical + Emotional = The Dual-Pathway Difference. This isn't incremental improvement. This is category creation.
GlowVido™: Daily Libido & Hormone Support
Purpose
Baseline maintenance protocol for women aged 35–60 experiencing HSDD, hypogonadism, or perimenopausal/menopausal symptoms. GlowVido™ sustains desire, mood, and hormonal harmony between GlowBido™ on-demand use.
Key Compounded Actives (Non-Sterile Oral Capsule)
  • DHEA: Androgen and adrenal support to restore baseline desire and energy
  • Bupropion SR: Dopaminergic mood enhancer proven to elevate libido and motivation
  • L-Arginine + L-Citrulline: Vascular flow precursors that enhance arousal and genital sensitivity
  • Estriol + Estradiol: Bio-identical hormones for tissue health, lubrication, and hormonal balance
  • B-Complex + L-Methylfolate: Neurotransmitter cofactors supporting serotonin, dopamine, and overall mental clarity
Clinical Effect & Dosing
Dosing: 1 capsule AM + 1 capsule PM daily
Effect: Sustains desire, mood stability, and hormonal harmony, creating the ideal biological foundation for GlowBido™ to deliver peak results.
Manufacturing Status
503B-compatible formulation using FDA-listed bulk ingredients. Scalable, high-margin production ready for immediate deployment.
GlowVido™ powers the daily balance that makes GlowStax™ work long-term. It's the foundation; GlowBido™ is the spark.
503B Exclusivity: Our Competitive Moat
Exclusive 503B Partner
Only one FDA-compliant 503B compounding facility in the U.S. is authorized to produce this exact formulation—and we have exclusive rights.
BelugaHealth Telehealth
Integrated HIPAA-secure telehealth platform, clinician network, and patient management infrastructure—ready to onboard thousands.
NimbusRx Fulfillment
Pharmacy fulfillment partner with nationwide shipping, discreet packaging, and automated refill systems built for subscription scale.
→ FDA compliant • HIPAA secure • Ready to ship today
This isn't a pitch for a product that could exist. This is infrastructure that's already operational—waiting for the brand and marketing engine to ignite it.
Infrastructure Advantage: Built, Tested, Ready Day One
What's Already In Place
  • U.S. 503B Compounding Partner with exclusive formulation rights
  • BelugaHealth telehealth platform and licensed clinician network
  • NimbusRx pharmacy fulfillment and automated subscription management
  • HIPAA-compliant patient portal and data security infrastructure
  • Regulatory compliance framework for 50-state telehealth operations
What This Means
No R&D lag. The products are formulated, tested, and production-ready.
No FDA wait. We're using FDA-approved compounds in a compliant 503B framework.
No infrastructure risk. Every operational piece—from clinician onboarding to patient fulfillment—is proven and scalable.
Built. Tested. Ready. The only thing missing is the brand that ignites demand—and that's what GlowStax™ delivers.
Financial Model & Pricing: High-Margin, Recurring Revenue
These are pharmaceutical-grade margins in a subscription model with 95% retention. Every patient acquired becomes an annuity—and the LTV numbers prove it.
95%
Retention Rate
Once women experience results, they don't leave—they become advocates
$3.8K
Lifetime Value
Average LTV per patient over 24+ months of consistent subscription
60d
Break-Even
Customer acquisition cost recovered in two months, then pure margin
Year 1–3 Growth Projection: Path to $239M ARR
This isn't speculative modeling. These projections are based on conservative customer acquisition rates, proven retention benchmarks from comparable telehealth categories, and gross margins validated by our 503B manufacturing partner.
The Billion-Dollar Trajectory
At 200,000 active subscribers—representing just 1.25% of the addressable U.S. market—GlowStax™ reaches $958M ARR. With an average LTV of $3,800 per patient and enterprise multiples in the 8–12x range for high-retention telehealth, we're building toward a $8–10B valuation at full scale.
Marketing Engine: Built for Scale, Optimized for Conversion
Paid Social & UGC
Meta, TikTok, and YouTube ads leveraging user-generated content and authentic testimonials. CAC ≈ $120 with 60-day break-even on first purchase.
SEO & Content
Educational blog content, clinical explainers, and long-tail keyword targeting to capture high-intent organic search traffic around HSDD, libido loss, and menopause.
Affiliate & Influencer Network
Partnerships with women's wellness influencers, menopause advocates, and relationship coaches who authentically align with the mission and audience.
Retention & Community
GlowClub™ membership drives repeat purchases, referrals, and viral word-of-mouth. Once women experience results, they become evangelists.
Day One—We're Not Testing. We're Scaling. The funnel, messaging, and creative are proven. We just need capital to pour gasoline on the fire.
Community Moat: GlowPsyche™
More Than a Product—A Movement
Women don't just buy GlowStax™. They join the movement. The private GlowPsyche™ community becomes a safe space for sharing stories, asking questions, and finding solidarity with thousands of others on the same journey.
This isn't a Facebook group. This is a curated, moderated, professionally supported community with expert Q&As, success stories, and peer connection that turns customers into lifelong advocates.
Retention Through Connection
Community-driven businesses enjoy 20–30% higher retention and 3x referral rates compared to transactional models. When women feel seen, supported, and celebrated, they don't churn—they bring their friends.
GlowPsyche™ is the retention moat that makes GlowStax™ not just a product, but a platform for transformation.
Proof of Desire: Real Women, Real Results
"After two weeks on GlowStax™, it felt like we had 'us' back. Not just the physical part—the laughter, the playfulness, the eye contact. I didn't realize how much I'd been going through the motions until I felt alive again."
— Samantha P., 42, marketing director
"The telehealth visit was so easy and respectful. I've been dismissed by doctors before, told it was 'just stress' or 'normal aging.' This clinician actually listened—and the treatment worked. I feel like myself for the first time in years."
— Marisol G., 38, registered nurse
"My mood shifted in days. I didn't expect that. I thought this was just about libido, but it's so much more—it's energy, confidence, feeling present in my own skin. Finally, I feel seen."
— Ari K., 47, small business owner
These aren't scripted testimonials. This is what happens when science meets empathy.
GlowClub™ Membership: Premium Retention Engine
$99 Concierge Plan
  • Priority clinician chat access
  • Early refill scheduling
  • Exclusive rewards program
  • VIP access to GlowPsyche™ events
  • Members-only product bundles
  • Personalized wellness check-ins
The Business Case
GlowClub™ converts one-time buyers into annual members, increasing ARPU (Average Revenue Per User) by 40%. Members stay subscribed 2x longer, refer 3x more friends, and provide predictable, recurring revenue that stabilizes cash flow and valuation multiples.
This isn't a loyalty program. It's a premium experience that makes women feel valued, supported, and committed to their wellness journey—with GlowStax™ as their trusted partner.
Joint Venture Blueprint with HexisMD
GlowStax™ Brings
Brand, intellectual property, marketing engine, creative assets, and demand generation expertise. We build the front-end that converts attention into patients.
HexisMD Brings
Telehealth infrastructure, clinician network, pharmacy fulfillment, patient management systems, and operational expertise. You provide the back-end that delivers care at scale.
Shared Success Model
60/40 Net Revenue Split (after COGS): GlowStax™ takes 60% for brand and marketing; HexisMD takes 40% for infrastructure and fulfillment. Aligned incentives, compounding growth.
GlowStax™ becomes the magnet that fills HexisMD funnels and unlocks cross-sell opportunities into GLP-1 weight management, hormone therapy, and longevity medicine. One patient acquisition feeds multiple revenue streams.
Financial Impact for HexisMD: The Multiplier Effect
This isn't just about the revenue from GlowStax™ subscriptions. It's about the patient pipeline that flows into every other HexisMD service. A woman who trusts you with her libido and hormonal wellness will trust you with weight management, metabolic health, and longevity optimization.
GlowStax™ is the front door to a lifetime relationship with HexisMD.
The Joint Venture Offer: Own a Category, Not Just a Campaign
💼
The Proposal
GlowStax™ supplies the brand, intellectual property, product formulations, and marketing engine. HexisMD provides launch capital and operational infrastructure. Together, we scale the first women's desire and hormone wellness platform with national reach.
Key Terms
  • 60/40 profit split after COGS
  • Initial launch capital: ≈ $250,000
  • 60-day break-even target
  • Scale-ready infrastructure for 50K+ active patients within 18 months
  • Exclusive partnership for GlowStax™ telehealth delivery in the U.S.
For $250K, HexisMD co-owns the fastest-growing category in women's health—zero build cost, zero R&D delay, billion-dollar upside.
Financial Partnership Snapshot: $250K to Ignite $1B+
💰
Goal: Launch GlowStax™ Nationwide with Zero Infrastructure Build
Capital Structure
40%
Lead Partner
HexisMD net profit share for capital and infrastructure
60%
GlowStax™
Brand and marketing net profit share
60d
Break-Even
Expected within two months of launch
$250K to ignite a $1B+ category. Minimal risk. Massive upside. The infrastructure exists. The demand exists. All we need is the spark.
The Partnership That Prints Money
The Reality
Most telehealth brands are trapped fighting over the same saturated markets—testosterone replacement therapy, GLP-1 weight loss, ED medications, men's hair loss. They spend more every month to acquire the same customer everyone else is targeting. Customer acquisition costs rise. Margins compress. Growth stalls.
Meanwhile, there's a billion-dollar women's wellness gap hiding in plain sight. No leader. No trusted brand. No emotional connection. No one solving the problem that 16 million women wake up with every single day.
The Question
What happens when one company finally fills that space—with science, credibility, empathy, and story?
That's what GlowStax™ is built to do.
The Infrastructure Is Already Built
🧩
You already have the engine. We bring the ignition.
What Exists Now
  • ✔ Licensed clinicians trained in women's health
  • ✔ Telehealth platform and HIPAA-compliant infrastructure
  • ✔ Pharmacy fulfillment and subscription management systems
  • ✔ Automated patient onboarding and refill workflows
  • ✔ 503B compounding partner with exclusive formulation rights
What's Missing
  • ⚡ A product that creates instant trust and emotional gravity
  • ⚡ A story that converts attention into lifelong patients
  • ⚡ A brand that customers stay loyal to and evangelize
  • ⚡ A marketing engine that scales predictably and profitably
Together, those two halves form the first full-stack women's wellness ecosystem—from desire → hormones → vitality. A platform that starts with the most emotionally charged need (libido) and expands into every dimension of women's health.
You built the house. We bring the light.
The Irresistible Close
🚀
Vision + logic = no-brainer.
Imagine This
Six months from today, the system is live. The patient funnels are overflowing. The retention curve rises every month. Women are sharing their stories. Referrals are accelerating. The brand is becoming synonymous with women's desire and empowerment.
The revenue is recurring, predictable, and high-margin. The community is growing organically. The cross-sell into other HexisMD services is compounding. Every patient acquired is an annuity—and a referral engine.
60/40 Profit Split
After COGS, aligned incentives for sustainable growth
We Handle Creative + Demand
Brand, marketing, content, conversion funnels
You Handle Telehealth + Fulfillment
Infrastructure, clinicians, pharmacy, patient care
Launch in 30 Days
From signed agreement to first patient onboarded
Break-Even in 60
Recover CAC within two months, then pure margin
There's a billion-dollar space waiting to be claimed. The infrastructure is ready. The audience is ready. The world is ready.
The only question is—who lights the spark first?
🔥 GlowStax™ — Ignite Now
Ignite Now
This is the moment. The market is ready. The infrastructure is ready. The only variable is decision.
The Exit Play: Build It or Sell It—Either Way, We Win
Scale Path
Build to $100M ARR within 3–4 years. At 8–10x revenue multiples typical for high-retention telehealth platforms, that's a $800M–$1B valuation.
Acquisition Path
Become the obvious acquisition target for Hims, Hers, Ro, or a major pharma player seeking to enter women's sexual wellness. Precedent: Nurx ($1.5B valuation), Tia ($100M Series B).
Either Way
GlowStax™ becomes the category-defining brand that every competitor either imitates or acquires. We own the narrative. We own the market. We own the outcome.
Either we own it—or they buy it. Both paths lead to generational wealth creation.
Final Card: Every Empire Began with One Product
Every Telehealth Empire
Began with One Product
That Changed Everything
Hims started with hair loss. Ro started with ED. Hers started with birth control. Each became a multi-billion-dollar platform because they solved one emotionally charged problem so well that customers trusted them with everything else.
GlowStax™ is that product for women's desire and hormonal wellness.
This isn't just a revenue opportunity. It's a brand-defining moment. It's the chance to be remembered as the company that gave women their spark back—that said "you matter" when everyone else looked away.
"Let's make HexisMD the brand that gave women their confidence, desire, and connection back."
Presenter Hooks: Open with Impact
When you present GlowStax™, start with one of these hooks to grab attention immediately and frame the conversation around the billion-dollar opportunity.
1
"What if every woman could reignite her spark in 60 seconds?"
Frames the product as immediate, transformative, and emotionally resonant.
2
"This is a $1B problem hiding in plain sight."
Emphasizes market size and the fact that no one is solving it—instant credibility and urgency.
3
"We own the first dual-pathway telehealth solution for women."
Positions GlowStax™ as a category creator, not a competitor—differentiation from the start.
4
"We're ready to ship today—no build, no risk."
Removes the biggest objection investors have: execution risk. The infrastructure exists.
5
"GlowStax™ is the Tesla of Women's Wellness."
Aspirational comparison that conveys innovation, premium positioning, and category disruption.
Why GlowStax™ Wins: The Unfair Advantages
Exclusive 503B Formulation
No competitor can replicate our exact dual-pathway stack without years of R&D and regulatory navigation. We have the only authorized compounding partner.
First-Mover in Blue Ocean
While everyone fights in saturated markets, we own an entirely uncontested $1B+ category with zero established competitors.
Operational Infrastructure Ready
No build delays, no hiring sprints, no regulatory uncertainty. Telehealth, fulfillment, and compounding are operational today.
High-Margin Recurring Revenue
56–68% gross margins on a subscription model with 95% retention and $3,800 LTV per patient. This is annuity-like revenue.
Emotional Moat Through Community
GlowPsyche™ creates retention, referrals, and brand loyalty that competitors can't buy with ads. Community is the ultimate competitive advantage.
Cross-Sell Multiplier Effect
Every GlowStax™ patient becomes a candidate for GLP-1, HRT, longevity, and vitality services—feeding the entire HexisMD ecosystem.
The Moment Is Now
Ignite Now
The market is ready. The infrastructure is ready. The women who need this are waiting. The only question left is: Who will lead?
GlowStax™ isn't just a product. It's a movement. A revolution. A reclaiming of desire, confidence, and connection for millions of women who've been told to accept less, to stay silent, to fade quietly.
We're not asking you to build something from scratch. We're asking you to light the match on something that's already built, already proven, and already poised to ignite.
"The billion-dollar space is open. The spark is ready. Let's ignite the future—together."
GlowStax™ × HexisMD
Confidence • Desire • Connection
🔥 Ignite Now